prednimustine has been researched along with Recrudescence in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ammendolia, I; Babini, L; Barbieri, E; Bendandi, M; Fiacchini, M; Gherlinzoni, F; Neri, S; Perini, F; Salvucci, M; Zinzani, PL | 1 |
Errante, D; Gastaldi, R; Magnani, G; Nigra, E; Nosari, AM; Spina, M; Tirelli, U; Vaccher, E | 1 |
Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S | 1 |
Bonadonna, G; Santoro, A; Valagussa, P | 1 |
3 trial(s) available for prednimustine and Recrudescence
Article | Year |
---|---|
CEP regimen (CCNU, etoposide, prednimustine) for relapsed/refractory Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednimustine; Recurrence; Survival Analysis; Treatment Outcome | 1994 |
Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednimustine; Prognosis; Prospective Studies; Recurrence; Survival Rate | 1996 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednimustine; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Recurrence; Vinblastine; Vincristine | 1986 |
1 other study(ies) available for prednimustine and Recrudescence
Article | Year |
---|---|
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine | 1990 |